Phylogenetic analysis of TALE superclass homeobox genes in amphipod crustaceans
The paper identifies and phylogenetically analyzes TALE class genes in amphipod crustaceans, revealing six subclasses and providing FASTA sequences.
Author
Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.
10 papers
Recent·Most cited
The paper identifies and phylogenetically analyzes TALE class genes in amphipod crustaceans, revealing six subclasses and providing FASTA sequences.
This study identifies common genetic and transcriptional alterations in AMPK pathway genes across cancers and shows their prognostic significance in multiple tumor types.
This study identifies JAK-STAT pathway genetic alterations across 21 cancer types and links them to survival outcomes and immune features, revealing pan-cancer immunoevasive strategies.
The paper analyzes PPAR pathway mutations across 21 cancers to identify driver genes and their associations with metabolism, immunity, and hypoxia.
This study identifies circadian clock genes with tumour-suppressive and oncogenic roles across 21 cancer types, showing their prognostic significance and interactions with hypoxia signalling.
The paper identifies a Notch-Hedgehog gene signature associated with cancer stem cells, showing its predictive value across five cancers and linking it to hypoxia and immunoevasion.
The paper identifies a core Wnt gene signature linked to genomic amplifications and poor prognosis across six cancer types.
The paper identifies a 10-gene DNA repair signature associated with poor prognosis in multiple cancers, linked to cell cycle dysregulation and tumor hypoxia.
W. H. Chang, D. Forde, A. G. Lai
The paper identifies two prognostic signatures of 2-oxoglutarate oxygenases in 10 cancers, showing associations with survival outcomes and potential roles in cell cycle regulation and cell adhesion.
W. H. Chang, D. Forde, A. G. Lai
The paper develops a 45-gene and an 8-gene signature combining hypoxia and immunoregulatory genes to predict prognosis across six cancer types, showing improved performance over existing staging parameters.